CAMP4 THERAPEUTICS CORPORATION
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +65.5% | -45.6% | +159.3% | -28.6% | -75.8% | +147.6% | -114.8% | – | – | – | – | |
| – | +8.8% | +129.9% | -2.2% | -57.4% | +138.2% | -5.6% | +3.6% | -96.1% | +91.1% | +1.1% | -3.4% | |
| – | +42.8% | +33.8% | +18.7% | +2.6% | +11.8% | +6.5% | -0.4% | -87.8% | +111.1% | +38.7% | -0.8% | |
| – | – | -133.3% | – | – | – | +193.5% | -85.5% | -76.6% | -141.3% | – | – | |
| – | -42.0% | +84.4% | +4.7% | +24.7% | +104.8% | -46.7% | +17.1% | -69.7% | -83.2% | -35.0% | -36.7% | |
| – | +948.1% | -49.7% | -42.0% | -17.6% | +201.6% | -79.2% | -44.7% | -46.9% | -83.2% | -35.0% | -44.9% | |
| – | – | – | – | – | +0.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | +246.2% | +13.0% | -69.5% | |
| – | – | -117.4% | -91.2% | – | -196.3% | -71.2% | -90.3% | – | -99.7% | +23,708.0% | +5.9% | |
| – | +603.7% | -143.4% | – | +218.5% | -220.3% | – | – | – | -153.5% | – | +79.6% | |
| – | +103.1% | -58.6% | +228.3% | -36.2% | -126.1% | – | -201.7% | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.